Table 2.
POAG incidence in ESRD patients, KTRs, and healthy controls.
| Group | N | POAG Incidence | Duration (person- years) | Incidence rate (/1,000 person-years) | Unadjusted | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |||||
| Healthy Control | 10,955 | 77 | 64,358.35 | 1.20 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||
| ESRD | 10,955 | 180 | 53,507.48 | 3.36 | 2.83 (2.17–3.70) | < 0.0001 | 2.95 (2.26–3.85) | < 0.0001 | 1.43 (0.97–2.12) | 0.07 |
| KTR | 10,955 | 200 | 62,107.74 | 3.22 | 2.69 (2.07–3.50) | < 0.0001 | 2.72 (2.09–3.54) | < 0.0001 | 1.41 (0.96–2.07) | 0.08 |
| ESRD | 10,955 | 180 | 53,507.48 | 3.36 | 1 (Ref.) | 1 (Ref.) | 1 (Reference) | |||
| KTR | 10,955 | 200 | 62,107.74 | 3.22 | 0.95 (0.78–1.17) | 0.65 | 0.928 (0.76–1.14) | 0.47 | 1.02 (0.83–1.26) | 0.84 |
Model 1: Cox proportional hazard (PH) regression model adjusted for age and sex.
Model 2: Cox proportional hazard (PH) regression model adjusted for age, sex, diabetes mellitus, hypertension, dyslipidemia, income, and Charlson comorbidity index.
POAG primary open-angle glaucoma, HR hazard ratio, CI confidence interval, ESRD end stage renal disease, KTR kidney transplantation recipients.